Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vertex Pharmaceuticals (VRTX) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (432)	7/22/2000 6:31:38 PM
From: Doc Bones	Read Replies (1) \| Respond to of 1169

Vertex the headline hot stock from a technical-chart perspective at WallStreetCity.com this weekend. This is one of the oldest, largest, and, I would guess, most visited stock sites. Disclaimer: I know very little about technical analysis, though I believe there's something to it, particularly since I knew some people who made a living at it (in commodities.) And allow me to point out that after I posted a very favorable technical article on SEPR, my only other technical post, SEPR took off like a rocket. Not saying that caused it, do your own DD - VooDoo :-) Doc wallstreetcity.com Today's Hottest Stocks Vertex Pharmaceuticals Bases Near Record Highs Shares of Vertex Pharmaceuticals, Inc. have been holding steady within a 10 percent basing formation during the past week after setting a new record high of 132-3/4 on July 12. ----- wallstreetcity.com Stock of the Hour Jul 21 2000 2:08PM CST Vertex Pharmaceuticals Bases Near Record Highs by Charles Rotblut, CFA Senior Analyst/Contributing Editor Shares of Vertex Pharmaceuticals, Inc. {VRTX: chart, messages} have been holding steady within a 10 percent basing formation during the past week after setting a new record high of 132-3/4 on July 12. The short-term basing formation is typical of the stock's sustained four-month upward trend that has resulted in a gain of 209 percent since April 14. VRTX is presently trading up 3-3/8 and appeared in the 3:00 p.m. EDT ProSearch run of Stocks Moving on Industry Strength. [Six-month chart of VRTX with volume and 14-2 Wilder RSI] The recent basing formation has allowed VRTX to consolidate after becoming overbought during a surge in late June and early July. This consolidation should position the stock for a continuation of its upward movement as VRTX is now no longer technically overextended, even though buying pressure continues to build. Investors may want to look for continued strength within the Drugs/Biotechnology industry group {.DBI} as an impetus for VRTX to rise into new record territory.